Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C, Chronic

Clinical trial condition

Hepatitis C, Chronic

Explore clinical trials studying Hepatitis C, Chronic. Study availability and eligibility vary by location and protocol.

699 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C, Chronic trial results

Completed

Benefit of DAA Therapy in HCV Monoinfected and HIV-HCV Coinfected Patients With Mixed Cryoglobulinemia

NCT03342261

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +16 more
Locations: Hospices Civils de Lyon - Croix-Rousse Hospital Lyon, France

View Trial Details

Completed

Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease

NCT02207088

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +29 more
Locations: Not specified

View Trial Details

Completed

Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin

NCT02508090

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Fundacion de Investigacion de Diego San Juan, Puerto Rico

View Trial Details

Completed

First in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

NCT01590407

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Biotrial Rennes, Brittany Region, France

Biotrial Paris, France

Arensia Chisinau, Moldova

Arensia Bucharest, Romania

View Trial Details

Completed

Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults

NCT02493855

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Not specified

View Trial Details

Completed

ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection

NCT02517515

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: Not specified

View Trial Details

Completed

A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection

NCT02716428

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +18 more
Locations: Southern California Research Center Coronado, California, United States

Bach and Godofsky Infectious Diseases Bradenton, Florida, United States

Gastro One Germantown, Tennessee, United States

Auckland Clinical Studies Auckland, New Zealand

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection

NCT02651194

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus (HCV) Infection, +15 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection

NCT02442284

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +18 more
Locations: Not specified

View Trial Details

Completed

APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and Ribavirin

NCT02850289

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Calgary, Alberta, Canada

Edmonton, Alberta, Canada

Edmonton, Alberta, Canada

Edmonton, Alberta, Canada

View all 46 locations

View Trial Details